Faculty profile

Chad Bousman

ResearcherMedical GeneticsUniversity of Calgary

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Calgary directory, so their courses may be missing. Find their university profile.

Chad Bousman

Researcher

Medical Genetics

Health Sciences

University of Calgary

Calgary, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
21 publications in the last five years, latest in 2026.
Senior (last) author on 4 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Adolescents Clinical Trial Major Depressive Disorder Pharmacogenetics Precision Medicine Primary Care

Latest papers

Pharmacogenomic testing for major depressive disorder in British Columbia, Canada: Recommendations from a public deliberation.
Journal of affective disorders · 2026
Barriers and facilitators to the implementation of pharmacogenomic testing for antidepressants use in primary care: a systematic review using the consolidated framework for implementation research.
The pharmacogenomics journal · 2026
Beyond enrichment: pharmacogenetic heterogeneity in treatment-resistant depression.
Pharmacogenetics and genomics · 2026

All 51 publications

Latest funding

Pharmacogenetic-guided antidepressant prescribing (PGx-GAP) in adolescents trial
CIHR · 2022 · Nominated PI
$608,175

All 1 grants and awards

51 publications.

Pharmacogenomic testing for major depressive disorder in British Columbia, Canada: Recommendations from a public deliberation.

Edwards L, Bentley C, O'Doherty KC, Bunka M, Pistawka C, Riches L, Ridgway L, Bousman C, Austin J, Bryan S

Journal of affective disorders2026

DOI: 10.1016/j.jad.2026.121910 PMID: 42092400

Barriers and facilitators to the implementation of pharmacogenomic testing for antidepressants use in primary care: a systematic review using the consolidated framework for implementation research.

Counihan M, Cushen D, Kwak S, Allen A, Fitzsimons Mac Giolla Chuda D, Romanska W, Nakchbandi I, Reynolds R, Bousman C, Ledwidge M, Gallagher J, Ryan C

The pharmacogenomics journal2026

DOI: 10.1038/s41397-026-00426-0 PMID: 42716951

Beyond enrichment: pharmacogenetic heterogeneity in treatment-resistant depression.

Roberts B, Miljevic A, Hennessy LA, Boax CA, Hoath K, Bousman C, Hood SD, Rodger J

Pharmacogenetics and genomics2026

DOI: 10.1097/fpc.0000000000000621 PMID: 42720407

Runx1 transcription factor modulates opioid analgesia and withdrawal in humans and rodents.

Leduc-Pessah H, McAllister BB, Sinha S, Stokes-Heck S, Nishizawa D, Fan CY, St-Pierre MK, Bradaia A, Defaye M, Burma NE, Damblon J, Muñoz-Pino E, Visser F, Dorion MF, Healy LM, Tang YM, Canet-Pons J, van den Hoogen NJ, Zhang Z, Antunes FTT, Piscopo VEC, Medina M, Fukuda KI, Ichinohe T, Nagashima M, Hayashida M, Johnson E, Agrawal A, Degenhardt L, Martin NG, Zamponi GW, Nelson EC, Altier C, Tremblay ME, Bousman C, Stifani S, De Koninck Y, Ikeda K, Biernaskie J, Trang T

Neuron2026

DOI: 10.1016/j.neuron.2025.11.018 PMID: 41619726

Pharmacogenetic-Guided Antidepressant Prescribing in Adolescents (PGx-GAP): Study Protocol for a Randomized Controlled Trial.

Shields M, McAusland L, Heintz M, Rittenbach K, Tsuyuki R, Box A, Emery J, Zwicker J, Arnold P, Newton A, Bousman C

Journal of personalized medicine2026Senior author

DOI: 10.3390/jpm16020125 PMID: 41745416

Differential DNA methylation and gene expression in stem cell-derived cardiomyocytes from patients with and without a history of clozapine-induced myocarditis.

Marques D, Spindola L, Narang A, Vaziri N, Stavrum A, Jayaram M, Thomas N, Pantelis C, Le Hellard S, Hemberger M, Dean W, Greenway S, Bousman C

Journal of psychiatry & neuroscience : JPN2025Senior author

DOI: 10.1139/jpn-25-0017 PMID: 41170773

Characterizing models for delivery of pharmacogenomic testing: a scoping review.

Waheed Z, Bunka M, Edwards L, Bousman C, Hoens A, Austin JJ, Bryan S

Pharmacogenomics2025

DOI: 10.1080/14622416.2025.2571387 PMID: 41084769

Advancing paroxetine treatment in depression: predicting remission and plasma concentration, and validating and updating therapeutic reference ranges.

Yuan R, Liao Y, Lu X, Kang Z, Guo J, Zhang Y, Sun Y, Lu Z, Sun J, Zhao G, Zhu Y, Yang Y, Feng X, Bousman C, Yue W

Translational psychiatry2025

DOI: 10.1038/s41398-025-03503-3 PMID: 40877220

Psychiatric Pharmacogenomic Testing: A Primer for Clinicians.

Brown LC, Zai G, Kennedy JL, Müller DJ, Tavakoli E, Bousman C, Maruf AA

The Psychiatric clinics of North America2025

DOI: 10.1016/j.psc.2025.01.004 PMID: 40348416

Associations between structural brain changes and blood neurofilament light chain protein in treatment-resistant schizophrenia.

Cilia BJ, Eratne D, Wannan C, Malpas C, Janelidze S, Hansson O, Everall I, Bousman C, Thomas N, Santillo AF, Velakoulis D, Pantelis C

The Australian and New Zealand journal of psychiatry2025

DOI: 10.1177/00048674241307906 PMID: 39754499

Something wrong or missing on this profile? Suggest a correction

Chad Bousman

Research

Latest papers

Latest funding

Pharmacogenomic testing for major depressive disorder in British Columbia, Canada: Recommendations from a public deliberation.

Barriers and facilitators to the implementation of pharmacogenomic testing for antidepressants use in primary care: a systematic review using the consolidated framework for implementation research.

Beyond enrichment: pharmacogenetic heterogeneity in treatment-resistant depression.

Runx1 transcription factor modulates opioid analgesia and withdrawal in humans and rodents.

Pharmacogenetic-Guided Antidepressant Prescribing in Adolescents (PGx-GAP): Study Protocol for a Randomized Controlled Trial.

Differential DNA methylation and gene expression in stem cell-derived cardiomyocytes from patients with and without a history of clozapine-induced myocarditis.

Characterizing models for delivery of pharmacogenomic testing: a scoping review.

Advancing paroxetine treatment in depression: predicting remission and plasma concentration, and validating and updating therapeutic reference ranges.

Psychiatric Pharmacogenomic Testing: A Primer for Clinicians.

Associations between structural brain changes and blood neurofilament light chain protein in treatment-resistant schizophrenia.

Pharmacogenetic-guided antidepressant prescribing (PGx-GAP) in adolescents trial

Frequent collaborators

Stirling Bryan

Ross Tsuyuki

Kaarina Kowalec

Christophe Altier

Jehannine Austin

Stefano Stifani

Yves De Koninck

Tuan Trang

Maja Tarailo-Graovac

Myriam Hemberger

Jennifer Zwicker

Fidel Vila-Rodriguez

Marie-Ève Tremblay

Paul Gordon

Quan Long

Paul Arnold

David Castle

Roumen Milev